ARTT Center of Excellence
Brenda Gannon, Ph.D., has been selected as a American Society for Pharmacology and Experimental Therapeutics (ASPET) 2016 Washington Fellow!
The mission of the ASPET Washington Fellows is to enable developing and early career scientists interested in science policy to learn about and become more engaged in public policy issues. Fellows develop an understanding of how public policy decisions made in Washington help shape and impact science policy, such as funding for the National Institutes of Health and other science agencies. This program helps fellows develop the skills and insights to become future leaders in science.
Fellows advocated on Capitol Hill, meeting with their Congressional delegation to advocate for biomedical research and increased funding for the NIH. Fellows also met with Members of Congress in their home district, act as a conduit to inform colleagues within their departments/institutions about federal legislative matters, write op-ed pieces to local papers and more. Lastly, Fellows attended the ASPET Annual Meeting at Experimental Biology in April 2016, where they met with the ASPET Science Policy Committee to discuss their experiences as a Fellow. ASPET provided training, support and advice for these activities, as the fellows serve a one-year term.
Last year, ASPET received the highest number of applications for the Fellowship program and all the applicants were strong making it the most competitive application process in the programs four year history. All applicants were carefully scrutinized and the top canididates were selected for the program.
Brenda conducts research in the lab of Gregory Collins, Ph.D., Pharmacology Assistant Professor/Research.
View the ASPET issue of the Pharmacologist announcing the 2016 ASPET Washington Fellows.
Congratulations Dr. Gannon!